Literatur
- 1
Abraczinskas D, Ookubo R. et al .
Propranolol for the prevention of first variceal bleeding: a lifetime commitment?.
Hepatology.
2001;
34
1096-1102
- 2
De Franchis R.
Evolving consensus in portal hypertension.
J Hepatol.
2005;
43
167-176
- 3
Garcia-Pagan J C, Bosch J.
Endoscopic band ligation in the treatment of portal hypertension.
Nat Clin Pract Gastroenterol Hepatol.
2005;
2
526-535
- 4
Groszmann R, Garcia-Tsao G. et al .
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.
N Engl J Med.
2005;
353
2254-2261
- 5
Imperiale T, Chalasani N.
A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal
variceal bleeding.
Hepatology.
2001;
33
802
- 6
Jutabha R, Jensen D M, Martin P. et al .
Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage
in cirrhotics with high risk esophageal varices.
Gastroenterology.
2005;
128
870-881
- 7
Khuroo M S, Khuroo N S, Farahat K LC, Khuroo Y S, Sofi A A, Dahab S T.
Meta-analysis: endoscopic variceal ligation for primary prophylaxis of esophageal
variceal bleeding.
Aliment Pharmacol Therap.
2005;
21
347-361
- 8
Lo G H. et al .
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients
with cirrhosis.
Gastrointest Endosc.
2004;
59
333-338
- 9
Lui H F, Stanley A J, Forrest E H. et al .
Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing
band ligation, propranolol, and isosorbide mononitrate.
Gastroenterology.
2002;
123
735-744
- 10
Merkel C. et al .
A placebo controlled trial of nadolol in the prophylaxis of growth of small esophageal
varices in cirrhosis.
Gastroenterology.
2004;
127
476-484
- 11
North Italian Endoscopic Club (NIEC) for the study and treatment of esophageal varices
.
Prediction of first variceal hemorrhage in patients with cirrhosis of the liver and
esophageal varices.
N Engl J Med.
1988;
319
983-989
- 12
Poynard T, Cales P, Pasta L. et al .
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in
patients with cirrhosis and esophageal varices.
N Engl J Med.
1991;
324
1532-1538
- 13
Sarin S K.
Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation
alone in primary prophylaxis of variceal bleeding.
Am J Gastroenterol.
2005;
100
797-804
- 14
Sarin S K. et al .
Comparison of endoscopic ligation and propranolol for the primary prevention of variceal
bleeding.
N Engl J Med.
1999;
340
988-993
- 15
Sauerbruch T, Wotzka R, Köpcke W. et al .
Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients
with cirrhosis.
N Engl J Med.
1988;
319
8-15
- 16
Schepke M, Kleber G, Nurnberg D. et al., German Study Group for the Primary Prophylaxis
of Variceal Bleeding .
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology.
2004;
40
65-72
- 17
Schepke M, Werner E, Biecker E. et al .
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients
with cirrhosis and portal hypertension.
Gastroenterology.
2001;
121
389-395
- 18
Thuluvath P J, Maheshwari A, Jagannath S. et al .
A randomized controlled trial of blockers versus endoscopic band ligation for primary
prophylaxis.
Dig Dis Sci.
2005;
50
407-410
- 19
Triantos C. et al .
Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers.
Aliment Pharmacol Ther.
2005;
21
1435-1443
Priv.-Doz. Dr. med. Michael Schepke
Medizinische Klinik und Poliklinik I, Allgemeine Innere Medizin, Universitätsklinik
Bonn
Sigmund-Freud-Straße 25
53127 Bonn
Phone: +49/228/2874338
Fax: +49/228/2871363
Email: Michael.Schepke@ukb.uni-bonn.de
